First FDA pregnancy-approved Pertussis vaccine to protect newborns
European Pharmaceutical Review
OCTOBER 10, 2022
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline Biologicals’ Boostrix vaccine for use in pregnant woman in their third trimester, to prevent against whooping cough (pertussis) in infants up to two months of age.
Let's personalize your content